Rohto’s Cirrhosis Cell Therapy Finds Japan Partner In Shionogi
Executive Summary
In a sign of continued corporate interest in the regenerative and cell therapy area in Japan, Shionogi has acquired rights in this market to a novel cirrhosis treatment being developed by Rohto.